Independent predictors of CRT implantation included lower EF, musculoskeletal disease, use of mineralocorticoid receptor antagonists (MRA), and use of anti-arrhythmic drugs (Figure 2). This evidence concerns the gene NR3C2 and musculoskeletal system disorder.